Light Mode
$29.04 ↑ +0.00 (+0.00%) Trading Up from the previous close of $29.04, $0.47 below the day’s high of $29.51
-4.36 (-13.05%) / 6M
Momentum, market sentiment, and recent alerts
SRZN reads neutral: price sits above both the 20- and 200-day averages, the 12-month move is +112.7%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Surrozen, Inc. is a clinical stage biotechnology company, which engages in the business of discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. The company was founded by K. Christopher Garcia and Roeland Nusse on August 12, 2015 and is headquartered in South San Francisco, CA.
No peer group available for this symbol.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.